3/31/2014 5:50:52 PM
by Richard Daverman, PhD
March 31, 2014 -- Bayer HealthCare will invest $138 million to expand its Beijing manufacturing facility. The plant is expected to meet growing demand for Bayer’s healthcare offerings, including products in the cardiovascular and diabetes sector. The expanded facility will house logistics areas for fully automated material handling, analytical laboratories and high-speed packaging lines. China is high on Bayer’s investment list. One month ago, it purchased Dihon Pharmaceutical Group, a TCM/over-the-counter drug maker. Although the price was undisclosed, it was thought to be around $680 million. More details....
Stock Symbol: (XETRA: BAYN)
Help employers find you! Check out all the jobs and post your resume.
comments powered by